ArticleLeukemia2026

Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamide.

Portia Smallbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.